REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Rozsa-Medicina Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Rozsa-Medicina Gyogyszertari Bt. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Rozsa-Medicina Bt. is a company in Hungary, with a head office in Budapest. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on May 15, 1996. It currently has a total number of 8 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 17.77% in 2023. Its’ total assets recorded a growth of 9.29%. Rozsa-Medicina Bt.’s net profit margin increased by 0.63% in 2023.

Headquarters
Gorgey Artur utca 28-30. fszt. 1.
Budapest; Budapest; Postal Code: 1041

Contact Details: Purchase the Rozsa-Medicina Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Rozsa-Medicina Bt. report to view the information.
Outstanding Shares:
Purchase the Rozsa-Medicina Bt. report to view the information.
Registered Capital:
Purchase the Rozsa-Medicina Bt. report to view the information.
Financial Auditors:
Purchase the Rozsa-Medicina Bt. report to view the information.
Incorporation Date:
May 15, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Rozsa-Medicina Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
17.77%▲
Total operating revenue
18.03%▲
Operating profit (EBIT)
22.28%▲
EBITDA
18.85%▲
Net Profit (Loss) for the Period
29.55%▲
Total assets
9.29%▲
Total equity
29.47%▲
Operating Profit Margin (ROS)
0.26%▲
Net Profit Margin
0.63%▲
Return on Equity (ROE)
0.06%▲
Quick Ratio
0.1%▲
Cash Ratio
0.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo